Only show
results from:

Sort results by:

Display preferences
331 results sorted by relevancy Results per page:
Pharmaceutical Pioneer Actelion Pharmaceuticals Ltd. Adopts Portfolio Management Solution for New Product Development from Artemis International.
Business Wire; Apr 27, 2004; 700+ Words ...Supports the Entire Pharmaceutical R & D Process Actelion Pharmaceuticals Ltd. (SWX:ATLN...pipeline of new pharmaceutical products that...NPD will help Actelion to manage its...Endothelium, Actelion will use the...
Study findings from Actelion Pharmaceuticals Ltd. broaden understanding of proteomics.
Biotech Week; Oct 15, 2008; 700+ Words ...contact C. Mangold, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH...Switzerland, Allschwil, Actelion Pharmaceuticals Ltd., Biotechnology Business...Neuropeptides, Peptide, Pharmaceutical Business, Pharmaceutical...
Research in the area of pharmacodynamics reported from Actelion Pharmaceuticals Ltd., Department of Clinical Pharmacology.(Report)
Biotech Week; May 6, 2009; 700+ Words ...contacting J. Dingemanse, Actelion Pharmaceuticals Ltd, Dept. of Clinical Pharmacology...Switzerland, Allschwil, Actelion Pharmaceuticals Ltd., Biotechnology Business...Hepatology, Liver Cirrhosis, Pharmaceutical Business, Pharmaceutical...
Findings in type 2 diabetes reported from Actelion Pharmaceuticals Ltd., Department of Clinical Pharmacology.(Clinical report)
Diabetes Week; Nov 9, 2009; 700+ Words ...contact P.N. Sidharta, Actelion Pharmaceuticals Ltd, Dept. of Clinical Pharmacology...Switzerland, Allschwil, Actelion Pharmaceuticals Ltd., Biotechnology Business...Dependent Diabetes Mellitus, Pharmaceutical Business, Pharmaceutical...
Oxford GlycoSciences PLC and Actelion Ltd. (Active Pharmaceutical Ingredient Watch).(EC approval for Zavesca)(Brief Article)
Chemical Market Reporter; Dec 2, 2002; 433 Words OXFORD GlycoSciences PLC and Actelion Ltd. have received EC approval for Zavesca (miglustat), the first oral treatment for patients with mild to moderate type 1 Gaucher's disease for whom enzyme replacement therapy is unsuitable.
Actelion Pharmaceuticals U.S. Deploys Model N Medicaid Claims Processing to Better Manage Governmental Compliance.
PR Newswire; Aug 1, 2005; 700+ Words ...reimbursement at Actelion Pharmaceuticals U.S. "Our...companies like Actelion Pharmaceuticals U.S. in many...mind for growing pharmaceutical companies such as Actelion, especially...About Actelion Ltd Actelion Ltd...
Actelion Pharmaceuticals U.S. Selects Model N Government Pricing to Enhance Regulatory Compliance Management.
PR Newswire; Mar 20, 2006; 700+ Words ...Reimbursement at Actelion Pharmaceuticals U.S. "Government...Government Pricing, Actelion has a tool to improve...that innovative pharmaceutical companies such as Actelion continue to expand...About Actelion Ltd Actelion Ltd is...
Actelion Pharmaceuticals US Selects I-many/Medicaid.
Business Wire; Jun 27, 2002; 700+ Words ...today that Actelion Pharmaceuticals US has selected and...many/Medicaid allows Actelion to market their first...many/Medicaid, Actelion is well positioned to...of future products. Actelion Pharmaceuticals US...is owned by Actelion Ltd, a biopharmaceutical...
Genentech Inc. (Active Pharmaceuticals Ingredient Watch).(Actelion Ltd. evaluation of cardiovascular prep)(Brief Article)
Chemical Market Reporter; Feb 18, 2002; 513 Words GENENTECH Inc. and Actelion Ltd. say a Phase III program evaluating Tracleer (bosentan) in chronic heart failure (CHF) failed to meet primary end points.
USPTO Issues Trademark RESTANA to Actelion Pharmaceuticals for Pharmaceutical Preparations
US Fed News Service, Including US State News; Oct 13, 2009; 498 Words ...Oct. 13 -- Actelion Pharmaceuticals Ltd., Allschwil...was sought are "Pharmaceutical preparations specially...antipsychotics; pharmaceutical preparations for smoking cessation; pharmaceutical preparations for...
Publication No. WO/2009/109906 Published on Sept. 11, Assigned to Actelion Pharmaceuticals for Pyridine Compound (Swiss, German, French Inventors)
US Fed News Service, Including US State News; Sep 15, 2009; 382 Words ...France, and Claus Mueller, Germany, have developed the pyridine compounds. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Publication No. WO/2009/109907 Published on Sept. 11, Assigned to Actelion Pharmaceuticals for Novel Pyrimidine-Pyridine Derivative (Swiss, German, French Inventors)
US Fed News Service, Including US State News; Sep 15, 2009; 391 Words ...Mueller, Germany, have developed the novel pyrimidine-pyridine derivatives. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Publication No. WO/2009/104152 Published on Aug. 27, Assigned to Actelion Pharmaceuticals for Ovarian Cancer Combination Treatment Method (Swiss Inventors)
US Fed News Service, Including US State News; Aug 29, 2009; 382 Words ...Switzerland, have developed a combination treatment method for ovarian cancer. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Publication No. WO/2009/104147 Published on Aug. 27, Assigned to Actelion Pharmaceuticals for Azatricyclic Antibiotic Compound (Swiss, French Inventors)
US Fed News Service, Including US State News; Aug 29, 2009; 364 Words ...Surivet, both of France, have developed the azatricyclic antibiotic compounds. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Patent No. 7,605,269 Issued on Oct. 20, Assigned to Actelion Pharmaceuticals for Thiophene Derivatives (Swiss, French, German Inventors)
US Fed News Service, Including US State News; Oct 24, 2009; 425 Words ...The inventors were issued U.S. Patent No. 7,605,269 on Oct. 20. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil. According to the abstract released by the U.S. Patent & Trademark Office: "The invention...
Publication No. WO/2009/104155 Published on Aug. 27, Assigned to Actelion Pharmaceuticals for Derivative (Swiss, French, German Inventors)
US Fed News Service, Including US State News; Aug 29, 2009; 397 Words ...Koberstein, Germany, have developed the 2-aza-bicyclo heptane derivatives. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Publication No. WO/2009/083899 Published on July 9, Assigned to Actelion Pharmaceuticals for Enantiomeric Thsubstituted Preparation (Austrian, Swiss, Dutch Inventors)
US Fed News Service, Including US State News; Jul 13, 2009; 419 Words ...of an enantiomeric thsubstituted 3,4-dihydro- isoquinoline derivative. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to a description of the invention, released by the World Intellectual...
Publication No. WO/2009/136379 Published on Nov. 12, Assigned to Actelion Pharmaceuticals for Derivative (French, Swiss Inventors)
US Fed News Service, Including US State News; Nov 16, 2009; 398 Words ...oxazolidin-2-one derivatives for treating bacterial intestinal diseases. The patent has been assigned to Actelion Pharmaceuticals Ltd, Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Publication No. WO/2009/128019 Published on Oct. 22, Assigned to Actelion Pharmaceuticals for Tricyclic Antibiotic (Swiss, French Inventors)
US Fed News Service, Including US State News; Oct 29, 2009; 369 Words ...Philippe Surivet, both of France, have developed tricyclic antibiotics. The patent has been assigned to Actelion Pharmaceuticals Ltd, Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
Publication No. WO/2009/109904 Published on Sept. 11, Assigned to Actelion Pharmaceuticals for Novel Aminomethyl Benzene Derivative (Swiss, German, French Inventors)
US Fed News Service, Including US State News; Sep 15, 2009; 391 Words ...Mueller, Germany, have developed the novel aminomethyl benzene derivatives. The patent has been assigned to Actelion Pharmaceuticals Ltd., Allschwil, Switzerland. According to an abstract posted by the World Intellectual Property Organization...
331 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives